Research Scientist in Pharmacology
2 weeks ago
Translational Pet Imaging Scientist We are seeking a motivated and experienced Translational Pet Imaging Scientist to lead the transition of novel PET radiotracers from late preclinical development into first-in-human studies. This role will primarily focus on clinical implementation of novel PET tracers in oncology studies, guide regulatory submissions, and act as the PET imaging expert within multidisciplinary project teams to ensure efficient clinical translation.
Strategy & Leadership: Develop and lead the clinical imaging strategy for application of novel PET tracers in early clinical oncology trials, guiding projects from late-stage preclinical work through clinical proof-of-concept studies.
Translational Study Design: Design, oversee, and interpret PET imaging studies in animal models and early-phase clinical trials (Phase I), ensuring robust study design and high-quality PET data collection.
Regulatory Support: Familiarity with regulatory and quality frameworks applicable to radiopharmaceuticals (GMP for radiopharmaceuticals, IND/CTA requirements, radiation safety/compliance). Prepare and contribute PET-specific scientific content for regulatory filings, including IND submissions.
Partner and Site Management: Coordinate with CROs, CDMOs, and clinical sites to support cGMP manufacturing logistics and clinical supply/distribution for radiopharmaceuticals. Manage relationships and deliverables with external academic collaborators and CROs/CDMOs.
Serve as the PET imaging subject-matter expert on project teams, working closely with biomarker scientists, clinical and medical leads, regulatory affairs, clinical operations, and CMC teams.
Interpret imaging data, author study reports, present findings internally and externally, and contribute to manuscripts and conference presentations.
D. or equivalent doctorate degree in Biomedical/Imaging Science, Radiochemistry, Physics, Pharmacology or a related field and seven (7) years of relevant experience.
Demonstrated experience advancing novel PET tracers into clinical studies, including collaboration with academic sites and contract partners for cGMP manufacturing. Strong understanding of radiopharmaceutical development, radiochemistry, and quality control; First-hand experience with regulatory pathways and requirements for novel PET tracers in early-phase clinical trials. Track record of interacting with regulatory agencies or primary contributor to successful agency submissions for novel PET imaging agents. Required Skills: Cancer Research, Clinical Trials, Oncology, Oncology Trials, Positron Emission Tomography (PET), Project Leadership, Radiation Safety, Radiopharmaceuticals, Radiopharmacy, Regulatory Compliance, Regulatory Work, Technical Leadership, Translational Research
-
RESEARCH SCIENTIST
1 week ago
San Diego, United States Scripps Research Full timeJob Details Description ABOUT US: Calibr-Skaggs Institute for Innovative Medicines was founded on the principle that the creation of new medicines can be accelerated by pairing world-class biomedical research with state-of-the-art drug discovery and development capabilities. Calibr-Skaggs is a division of Scripps Research, a first-of-its-kind, nonprofit...
-
San Francisco, United States Revolution Medicines Full timeScientist II, Cancer Pharmacology, Translational ResearchJoin to apply for the Scientist II, Cancer Pharmacology, Translational Research role at Revolution MedicinesScientist II, Cancer Pharmacology, Translational ResearchJoin to apply for the Scientist II, Cancer Pharmacology, Translational Research role at Revolution MedicinesGet AI-powered advice on this...
-
South San Francisco, United States BBOT Full timeAbout BBOT: BBOT is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio Services, BBOT completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with...
-
South San Francisco, California, United States BBOT Full timeDescriptionAbout BBOT:BBOT is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio Services, BBOT completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for...
-
Research Scientist, Pharmacology/Drug Discovery
4 weeks ago
Palo Alto, CA, United States GondolaBio, LLC Full timeAll Jobs Principal Scientist, Translational Research Principal Scientist, Translational Research GondolaBio is a collection of biopharmaceutical companies focused on developing nextgeneration therapeutics for genetic diseases. Originally carved out of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an...
-
Research Scientist, Pharmacology/Drug Discovery
4 weeks ago
Palo Alto, CA, United States GondolaBio Full timePrincipal Scientist, Translational Research Join to apply for the Principal Scientist, Translational Research role at GondolaBio . GondolaBio is a collection of biopharmaceutical companies focused on developing next-generation therapeutics for genetic diseases. Originally carved out of BridgeBio, GondolaBio secured $300M in private financing from...
-
Research Associate I
2 weeks ago
San Diego, United States BioLegacy Research Full timeJoin to apply for the Research Associate I - In Vivo Pharmacology role at BioLegacy ResearchJoin to apply for the Research Associate I - In Vivo Pharmacology role at BioLegacy ResearchThis range is provided by BioLegacy Research. Your actual pay will be based on your skills and experience — talk with your recruiter to learn more.Base pay range$22.00/hr -...
-
Scientist, In Vitro Pharmacology
1 week ago
San Francisco, California, United States Work In Biotech Full timeJob Title: Research ScientistCompany:Stealth-mode Biotech (Protein-based Radioligand Therapeutics)About the CompanyWe are an early-stage, venture-backed biotechnology company operating in stealth mode, developing a novel platform for protein-based radioligand therapies. Our mission is to transform the precision oncology landscape by integrating protein...
-
Research Scientist, Pharmacology/Drug Discovery
4 weeks ago
Palo Alto, CA, United States GondolaBio Service Co Full timeSenior / Principal Scientist, Oligonucleotide Discovery (siRNA / ASO) GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally carved out in 2024 after securing $300M in private financing from external investors....
-
Research Scientist, Pharmacology/Drug Discovery
2 weeks ago
Palo Alto, CA, United States GondolaBio Full timeSenior/Principal Scientist, Oligonucleotide Discovery (siRNA/ASO) GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally carved out in 2024 after securing $300M in private financing from external investors. GondolaBio...
